Your browser doesn't support javascript.
loading
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial.
Tanriover, Mine Durusu; Aydin, Ozlem Altuntas; Guner, Rahmet; Yildiz, Orhan; Celik, Ilhami; Doganay, Hamdi Levent; Kose, Sukran; Akhan, Sila; Akalin, Emin Halis; Sezer, Zafer; Ozdarendeli, Aykut; Unal, Serhat.
Affiliation
  • Tanriover MD; Department of Internal Medicine, Hacettepe University Faculty of Medicine, 06230 Ankara, Türkiye.
  • Aydin OA; Vaccine Institute, Hacettepe University, 06230 Ankara, Türkiye.
  • Guner R; Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Türkiye.
  • Yildiz O; Infectious Diseases and Clinical Microbiology Clinic, Ankara Yildirim Beyazit University, Ankara City Hospital, 06800 Ankara, Türkiye.
  • Celik I; Department of Infectious Diseases and Clinical Microbiology, Erciyes University Faculty of Medicine, 38030 Kayseri, Türkiye.
  • Doganay HL; Department of Infectious Diseases and Clinical Microbiology, Kayseri City Training and Research Hospital, 38080 Kayseri, Türkiye.
  • Kose S; Department of Gastroenterology, Medical Park Pendik Hospital, 34899 Istanbul, Türkiye.
  • Akhan S; Department of Internal Medicine, Bahcesehir University School of Medicine, 34734 Istanbul, Türkiye.
  • Akalin EH; Infectious Diseases Clinic, University of Health Sciences, Izmir Tepecik Training and Research Hospital, 35020 Izmir, Türkiye.
  • Sezer Z; Department of Infectious Diseases and Clinical Microbiology, Kocaeli University Faculty of Medicine, 41001 Kocaeli, Türkiye.
  • Ozdarendeli A; Department of Infectious Diseases and Clinical Microbiology, Bursa Uludag University Faculty of Medicine, 16059 Bursa, Türkiye.
  • Unal S; Department of Medical Pharmacology, Erciyes University Faculty of Medicine, 38030 Kayseri, Türkiye.
  • On Behalf Of The Turkovac Study Group; Department of Microbiology, Erciyes University Faculty of Medicine, 38030 Kayseri, Türkiye.
Vaccines (Basel) ; 10(11)2022 Nov 04.
Article in En | MEDLINE | ID: mdl-36366373

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies Language: En Journal: Vaccines (Basel) Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies Language: En Journal: Vaccines (Basel) Year: 2022 Document type: Article